23Mar 2025
TRAM-B Shows Comparable Survival in Orbital Invasive Fungal Sinusitis

TRAM-B Shows Comparable Survival in Orbital Invasive Fungal Sinusitis

A study on acute invasive fungal rhinosinusitis (AIFRS) found that transcutaneous retrobulbar amphotericin (TRAM-B) is a viable alternative to orbital exenteration for managing orbital disease. Among 95 patients, TRAM-B did not worsen mortality outcomes, with a 53.1% survival rate. Careful monitoring is essential, as disease progression remains a concern. These findings support TRAM-B as a potential treatment option.

  • #ent

Like

Save

Share